- Home
- INTS vs AIHS Comparison
INTS vs AIHS Comparison
Compare INTS & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- AIHS
- Stock Information
- Founded
- INTS 2012
- AIHS 2014
- Country
- INTS United States
- AIHS China
- Employees
- INTS N/A
- AIHS N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- AIHS Finance: Consumer Services
- Sector
- INTS Health Care
- AIHS Finance
- Exchange
- INTS Nasdaq
- AIHS Nasdaq
- Market Cap
- INTS 8.7M
- AIHS 9.9M
- IPO Year
- INTS 2023
- AIHS 2018
- Fundamental
- Price
- INTS $0.50
- AIHS $0.94
- Analyst Decision
- INTS Strong Buy
- AIHS
- Analyst Count
- INTS 3
- AIHS 0
- Target Price
- INTS $8.50
- AIHS N/A
- AVG Volume (30 Days)
- INTS 396.2K
- AIHS 22.7K
- Earning Date
- INTS 05-13-2025
- AIHS 06-26-2025
- Dividend Yield
- INTS N/A
- AIHS N/A
- EPS Growth
- INTS N/A
- AIHS N/A
- EPS
- INTS N/A
- AIHS N/A
- Revenue
- INTS N/A
- AIHS $5,878,700.00
- Revenue This Year
- INTS N/A
- AIHS N/A
- Revenue Next Year
- INTS N/A
- AIHS N/A
- P/E Ratio
- INTS N/A
- AIHS N/A
- Revenue Growth
- INTS N/A
- AIHS 12.21
- 52 Week Low
- INTS $0.50
- AIHS $0.77
- 52 Week High
- INTS $5.28
- AIHS $1.45
- Technical
- Relative Strength Index (RSI)
- INTS 18.57
- AIHS 52.38
- Support Level
- INTS $0.46
- AIHS $0.89
- Resistance Level
- INTS $0.59
- AIHS $1.06
- Average True Range (ATR)
- INTS 0.05
- AIHS 0.05
- MACD
- INTS 0.02
- AIHS 0.00
- Stochastic Oscillator
- INTS 21.14
- AIHS 42.86
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.